Description
An inhibitor of GSK3 (34% inhibition when used at a concentration of 2.5 µM); inhibits androgen receptor transactivation and translocation to the nucleus in PCa prostate cancer cells; increases nuclear export of the androgen receptor in PC3 prostate cancer cells; dose-dependently potentiates peak current densities
Formal name: 5,6,7,8-tetrahydro-N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl-4-quinazolinamine
Synonyms: Glycogen Synthase Kinase 3 Inhibitor XIII
Molecular weight: 305.4
CAS: 404828-08-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|GSK3||Product Type|Biochemicals|Receptor Pharmacology||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|GSK3 Signaling